Other Issues:		[Index by Author]
Contents:	Volume 27, Issue 16 June 1, 2009

	PERSPECTIVES IN ONCOLOGY
	EDITORIALS
	ORIGINAL REPORTS
	Genitourinary Cancer
	Gastrointestinal Cancer
	Breast Cancer
	Translational Oncology
	Thoracic Oncology
	Leukemia and Bone Marrow Transplantation
	Pediatric Oncology
	Gynecologic Cancer
	Phase I and Clinical Pharmacology
	REVIEW ARTICLE
	DIAGNOSIS IN ONCOLOGY
	ART OF ONCOLOGY
	CORRESPONDENCE
	ERRATA

Find articles in this issue containing these words: [Search ALL Issues]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

                                      PERSPECTIVES IN ONCOLOGY

To Make Progress in Rare Cancers, Patients Must Lead the Way Amy Dockser Marcus JCO Jun 2009: 2575–2577. First published on May 4 2009; 10.1200/JCO.2009.21.9212. [Full Text] [PDF]

                                      EDITORIALS

Irinogenetics: How Many Stars Are There in the Sky? Ron H.J. Mathijssen and Howard Gurney JCO Jun 2009: 2578–2579. First published on Apr 6 2009; 10.1200/JCO.2008.21.2480. [Full Text] [PDF]

Are We Hitting the Right Combination for Hormonally Sensitive Breast Cancer? Debu Tripathy JCO Jun 2009: 2580–2582. First published on Apr 20 2009; 10.1200/JCO.2008.21.2142. [Full Text] [PDF]

Biomarkers of Therapeutic Response in Melanoma and Renal Cell Carcinoma: Potential Inroads to Improved Immunotherapy John M. Kirkwood and Ahmad A. Tarhini JCO Jun 2009: 2583–2585. First published on Apr 13 2009; 10.1200/JCO.2008.21.1540. [Full Text] [PDF]

Phase 0 Clinical Trials: An Answer to Drug Development Stagnation? Patricia M. LoRusso JCO Jun 2009: 2586–2588. First published on Apr 13 2009; 10.1200/JCO.2008.21.5798. [Full Text] [PDF] [French PDF]

Toward Noninvasive Genomic Screening of Lung Cancer Patients Lecia V. Sequist, Jeffrey A. Engelman, and Thomas J. Lynch JCO Jun 2009: 2589–2591. First published on May 4 2009; 10.1200/JCO.2008.20.4875. [Full Text] [PDF]

                                      ORIGINAL REPORTS
Genitourinary Cancer

Phase II Clinical Trial of Neoadjuvant Alternating Doublet Chemotherapy With Ifosfamide/Doxorubicin and Etoposide/Cisplatin in Small-Cell Urothelial Cancer Arlene O. Siefker-Radtke, Ashish M. Kamat, H. Barton Grossman, Dallas L. Williams, Wei Qiao, Peter F. Thall, Colin P. Dinney, and Randall E. Millikan JCO Jun 2009: 2592–2597. First published on May 4 2009; 10.1200/JCO.2008.19.0256. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer

Phase II Study of Capecitabine and Oxaliplatin for Advanced Adenocarcinoma of the Small Bowel and Ampulla of Vater Michael J. Overman, Gauri R. Varadhachary, Scott Kopetz, Rosni Adinin, E. Lin, Jeffrey S. Morris, Cathy Eng, James L. Abbruzzese, and Robert A. Wolff JCO Jun 2009: 2598–2603. First published on Jan 21 2009; 10.1200/JCO.2008.19.7145. [Abstract] [Full Text] [PDF]

Comprehensive Pharmacogenetic Analysis of Irinotecan Neutropenia and Pharmacokinetics Federico Innocenti, Deanna L. Kroetz, Erin Schuetz, M. Eileen Dolan, Jacqueline Ramírez, Mary Relling, Peixian Chen, Soma Das, Gary L. Rosner, and Mark J. Ratain JCO Jun 2009: 2604–2614. First published on Apr 6 2009; 10.1200/JCO.2008.20.6300. [Abstract] [Full Text] [PDF]

Long-Term Outcome of Cirrhotic Patients With Early Hepatocellular Carcinoma Treated With Ultrasound-Guided Percutaneous Laser Ablation: A Retrospective Analysis Claudio Maurizio Pacella, Giampiero Francica, Francesca Marta Lilja Di Lascio, Vincenzo Arienti, Ettore Antico, Bruno Caspani, Fabrizio Magnolfi, Angelo Salomone Megna, Stefano Pretolani, Renato Regine, Massimo Sponza, and Roberto Stasi JCO Jun 2009: 2615–2621. First published on Mar 30 2009; 10.1200/JCO.2008.19.0082. [Abstract] [Full Text] [PDF] [Publisher's Note]

PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer Fotios Loupakis, Luca Pollina, Irene Stasi, Annamaria Ruzzo, Mario Scartozzi, Daniele Santini, Gianluca Masi, Francesco Graziano, Chiara Cremolini, Eliana Rulli, Emanuele Canestrari, Niccola Funel, Gaia Schiavon, Iacopo Petrini, Mauro Magnani, Giuseppe Tonini, Daniela Campani, Irene Floriani, Stefano Cascinu, and Alfredo Falcone JCO Jun 2009: 2622–2629. First published on Apr 27 2009; 10.1200/JCO.2008.20.2796. [Abstract] [Full Text] [PDF]

Breast Cancer

Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer José Baselga, Vladimir Semiglazov, Peter van Dam, Alexey Manikhas, Meritxell Bellet, José Mayordomo, Mario Campone, Ernst Kubista, Richard Greil, Giulia Bianchi, Jutta Steinseifer, Betty Molloy, Erika Tokaji, Humphrey Gardner, Penny Phillips, Michael Stumm, Heidi A. Lane, J. Michael Dixon, Walter Jonat, and Hope S. Rugo JCO Jun 2009: 2630–2637. First published on Apr 20 2009; 10.1200/JCO.2008.18.8391. [Abstract] [Full Text] [PDF] [French PDF]

Radiotherapy and Adjuvant Trastuzumab in Operable Breast Cancer: Tolerability and Adverse Event Data From the NCCTG Phase III Trial N9831 Michele Y. Halyard, Thomas M. Pisansky, Amylou C. Dueck, Vera Suman, Lori Pierce, Larry Solin, Larry Marks, Nancy Davidson, Silvana Martino, Peter Kaufman, Leila Kutteh, Shaker R. Dakhil, and Edith A. Perez JCO Jun 2009: 2638–2644. First published on Apr 6 2009; 10.1200/JCO.2008.17.9549. [Abstract] [Full Text] [PDF] [French PDF] [Czech PDF]

Translational Oncology

Serum Vascular Endothelial Growth Factor and Fibronectin Predict Clinical Response to High-Dose Interleukin-2 Therapy Marianna Sabatino, Seunghee Kim-Schulze, Monica C. Panelli, David Stroncek, Ena Wang, Bret Taback, Dae Won Kim, Gail DeRaffele, Zoltan Pos, Francesco M. Marincola, and Howard L. Kaufman JCO Jun 2009: 2645–2652. First published on Apr 13 2009; 10.1200/JCO.2008.19.1106. [Abstract] [Full Text] [PDF]

Thoracic Oncology

Epidermal Growth Factor Receptor Mutations in Plasma DNA Samples Predict Tumor Response in Chinese Patients With Stages IIIB to IV Non–Small-Cell Lung Cancer Hua Bai, Li Mao, hang Shu Wang, Jun Zhao, Lu Yang, tong Tong An, Xin Wang, chun Jian Duan, na Mei Wu, zhi Qing Guo, yi Xu Liu, hong Ning Liu, ye Yu Wang, and Jie Wang JCO Jun 2009: 2653–2659. First published on May 4 2009; 10.1200/JCO.2008.17.3930. [Abstract] [Full Text] [PDF]

Genome-Wide Analysis of Survival in Early-Stage Non–Small-Cell Lung Cancer Yen-Tsung Huang, Rebecca S. Heist, Lucian R. Chirieac, Xihong Lin, Vidar Skaug, Shanbeh Zienolddiny, Aage Haugen, Michael C. Wu, Zhaoxi Wang, Li Su, Kofi Asomaning, and David C. Christiani JCO Jun 2009: 2660–2667. First published on May 4 2009; 10.1200/JCO.2008.18.7906. [Abstract] [Full Text] [PDF]

Leukemia and Bone Marrow Transplantation

Improved Outcome of Acute Promyelocytic Leukemia With High WBC Counts Over the Last 15 Years: The European APL Group Experience Charikleia Kelaidi, Sylvie Chevret, Stéphane De Botton, Emmanuel Raffoux, Agnès Guerci, Xavier Thomas, Arnaud Pigneux, Thierry Lamy, Françoise Rigal-Huguet, Sandrine Meyer-Monard, Patrice Chevallier, Frédéric Maloisel, Erick Deconinck, Augustin Ferrant, Nathalie Fegueux, Norbert Ifrah, Miguel Sanz, Hervé Dombret, Pierre Fenaux, and Lionel Adès JCO Jun 2009: 2668–2676. First published on May 4 2009; 10.1200/JCO.2008.18.4119. [Abstract] [Full Text] [PDF] [Publisher's Note]

Pediatric Oncology

Fertility of Female Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study Daniel M. Green, Toana Kawashima, Marilyn Stovall, Wendy Leisenring, Charles A. Sklar, Ann C. Mertens, Sarah S. Donaldson, Julianne Byrne, and Leslie L. Robison JCO Jun 2009: 2677–2685. First published on Apr 13 2009; 10.1200/JCO.2008.20.1541. [Abstract] [Full Text] [PDF]

Gynecologic Cancer

Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group David S. Miller, John A. Blessing, Carolyn N. Krasner, Robert S. Mannel, Parviz Hanjani, Michael L. Pearl, Steven E. Waggoner, and Cecelia H. Boardman JCO Jun 2009: 2686–2691. First published on Mar 30 2009; 10.1200/JCO.2008.19.2963. [Abstract] [Full Text] [PDF]

Phase I and Clinical Pharmacology

Prospective Validation of a Prognostic Score to Improve Patient Selection for Oncology Phase I Trials Hendrik-Tobias Arkenau, Jorge Barriuso, David Olmos, Joo Ern Ang, Johann de Bono, Ian Judson, and Stan Kaye JCO Jun 2009: 2692–2696. First published on Mar 30 2009; 10.1200/JCO.2008.19.5081. [Abstract] [Full Text] [PDF]

[18F]Fluorodeoxyglucose Positron Emission Tomography Correlates With Akt Pathway Activity but Is Not Predictive of Clinical Outcome During mTOR Inhibitor Therapy Wen Wee Ma, Heather Jacene, Dongweon Song, Felip Vilardell, Wells A. Messersmith, Dan Laheru, Richard Wahl, Chris Endres, Antonio Jimeno, Martin G. Pomper, and Manuel Hidalgo JCO Jun 2009: 2697–2704. First published on Apr 20 2009; 10.1200/JCO.2008.18.8383. [Abstract] [Full Text] [PDF]

Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies Shivaani Kummar, Robert Kinders, Martin E. Gutierrez, Larry Rubinstein, Ralph E. Parchment, Lawrence R. Phillips, Jiuping Ji, Anne Monks, Jennifer A. Low, Alice Chen, Anthony J. Murgo, Jerry Collins, Seth M. Steinberg, Helen Eliopoulos, Vincent L. Giranda, Gary Gordon, Lee Helman, Robert Wiltrout, Joseph E. Tomaszewski, and James H. Doroshow JCO Jun 2009: 2705–2711. First published on Apr 13 2009; 10.1200/JCO.2008.19.7681. [Abstract] [Full Text] [PDF] [French PDF]

                                      REVIEW ARTICLE

Perspectives for Cancer Prevention With Natural Compounds A.R.M. Ruhul Amin, Omer Kucuk, Fadlo R. Khuri, and Dong M. Shin JCO Jun 2009: 2712–2725. First published on May 4 2009; 10.1200/JCO.2008.20.6235. [Abstract] [Full Text] [PDF]

                                      DIAGNOSIS IN ONCOLOGY

Neonatal Congenital Malignant Melanoma With Lymph Node Metastasis Shannon Tierney McElearney, Lynn T. Dengel, Ann Byron Robertson Vaughters, James W. Patterson, Eugene D. McGahren, and Craig L. Slingluff, Jr JCO Jun 2009: 2726–2728. First published on Apr 6 2009; 10.1200/JCO.2008.20.7258. [Full Text] [PDF]

                                      ART OF ONCOLOGY

The Blood of the Lamb David P. Steensma JCO Jun 2009: 2729–2731. First published on Apr 20 2009; 10.1200/JCO.2008.21.1821. [Full Text] [PDF]

                                      CORRESPONDENCE

Cancer Is Heterogeneous Jean Marc Guinebretiere JCO Jun 2009: 2732. First published on Apr 20 2009; 10.1200/JCO.2008.21.7646. [Full Text] [PDF]

Is Immunohistochemistry Less Sensitive Than Quantitative Reverse Transcriptase Polymerase Chain Reaction for Hormone Receptor Status Determination in Breast Cancer? Laurent Arnould, Bruno Coudert, and Pierre Fumoleau JCO Jun 2009: 2733. First published on Apr 20 2009; 10.1200/JCO.2009.22.0269. [Full Text] [PDF]

Reply to J.M. Guinebretiere and L. Arnould et al Sunil S. Badve, Frederick L. Baehner, Robert P. Gray, Barrett H. Childs, Tara Maddala, Mei-Lan Liu, Steve C. Rowley, Steven Shak, Edith A. Perez, Lawrence J. Shulman, Silvana Martino, Nancy E. Davidson, George W. Sledge, Lori J. Goldstein, and Joseph A. Sparano JCO Jun 2009: 2734–2735. First published on Apr 20 2009; 10.1200/JCO.2009.21.8685. [Full Text] [PDF]

Chemotherapy and Radiation Resistance: Version 2.0 Jaffer A. Ajani JCO Jun 2009: 2735–2736. First published on Apr 27 2009; 10.1200/JCO.2008.21.7570. [Full Text] [PDF]

Reply to J.A. Ajani Rob Glynne-Jones, Mark Harrison, and Suzy Mawdsley JCO Jun 2009: 2737–2738. First published on Apr 27 2009; 10.1200/JCO.2009.21.8693. [Full Text] [PDF]

Tumor Lysis Syndrome in Solid Tumors Cengiz Gemici JCO Jun 2009: 2738–2739. First published on Apr 20 2009; 10.1200/JCO.2009.22.4154. [Full Text] [PDF]

Reply to C. Gemici Geum Youb Noh, Du Hwan Choe, Cheol Hyeon Kim, and Jae Cheol Lee JCO Jun 2009: 2739. First published on Apr 20 2009; 10.1200/JCO.2009.22.5672. [Full Text] [PDF]

Development and Application of a Real-Time On-Line Blinded Independent Central Review of Interim Pet Scans to Determine Treatment Allocation in Lymphoma Trials Michel Meignan, Emmanuel Itti, Stéphane Bardet, Jean Lumbroso, Véronique Edeline, Pierre Olivier, Thierry Vander Borght, Oumedaly Reman, Gilles Karcher, Olivier Mundler, Nicolas Mounier, Romain Ricci, Massimo Federico, John Raemaekers, and Marc André JCO Jun 2009: 2739–2741. First published on Apr 27 2009; 10.1200/JCO.2009.22.4089. [Full Text] [PDF] [Publisher's Note]

                                      ERRATA

ERRATUM JCO Jun 2009: 2742. [Full Text] [PDF]

ERRATUM JCO Jun 2009: 2742. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.